Brain-computer interfaces; PRIMA retinal implant for late-stage macular degeneration
Science Corporation (Alameda, United States) — brain-computer interfaces; PRIMA retinal implant for late-stage macular degeneration. On November 17, 2026 it announced a $400M Series D at $3.5B (reported), led by Khosla Ventures. The $3.5B valuation comes from a source cited by TechCrunch, not the company. Total raised over $900M. Prior: $230M Series C (Mar 2026) at a reported $1.5B. Funds go to PRIMA's EU rollout and US FDA approval.
Healthcare📍 Alameda
Current Valuation
$3.5B
as of 2026-11
UNICORN
QL Price
$3.5B
0% vs last round
QuantLogix's current estimate for Science Corporation, published 2026-11-22 — in line with the last disclosed round of $3.5B (2026-11).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$3.5B
2026-11
weight 0.96
How this price has held up
No round has priced for Science Corporation since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-11-22 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Science Corporation, 2026-11-22 (151f2ca58f723a4f).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Science Corporation going public?
No. Science Corporation is private and has not filed to go public. There is no S-1 on file.
What is Science Corporation's valuation in 2026?
Science Corporation is valued at $3.5B as of Nov 2026, set by its Series D ($400M, Nov 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Science Corporation filed an S-1?
No public S-1 is on file for Science Corporation.
Who are Science Corporation's investors?
Science Corporation's investors include Khosla Ventures.
How much has Science Corporation raised?
Science Corporation has raised $900M in total across 1 disclosed round, most recently a Series D of $400M in Nov 2026.
Is Science Corporation publicly traded — can you buy Science Corporation stock?
No. Science Corporation is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Science Corporation on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
HQ
Alameda
Total Raised
$900M
Last Round
Series D — $400M (Nov 2026) · Lead: Khosla Ventures
Exchange calendar terms from licensed market-data feeds. Expected dates marked est. are news-derived, not exchange-confirmed. Educational only, not a listing prediction.
Fundraising Status
Series D · $400M · this month
privateTotal raised $900M1 disclosed rounds
Series D Impact
Round Size
$400M
Primary financing announced
Post-Money Valuation
$3.5B
Company-announced mark
Round / Post-Money
11.4%
New capital ÷ post-money
Disclosed Funding
$900M
Cumulative disclosed rounds
Step-up compares disclosed post-money valuations. Round / post-money is a financing-size ratio, not an ownership or dilution estimate.
Hiring data for Science Corporation has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
Investors
Khosla Ventures
HealthcareBrain-computer interfaces
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-11. Refreshed quarterly.